Skip to main content
. 2020 Jan 25;157(6):1606–1616. doi: 10.1016/j.chest.2019.12.037

Figure 1.

Figure 1

Comparison of median biomarker levels by REVEAL Registry risk category: A, NT-proBNP; B, Gal3; C, ST2. Gal3 = galectin 3; NT-proBNP = N-terminal brain natriuretic peptide prohormone; REVEAL Registry = Registry to Evaluate Early and Long-Term PAH Disease Management; ST2 = soluble suppression of tumorigenicity 2.